Future Market Insights (FMI), a leading provider of market intelligence and consulting services, has unveiled a comprehensive report projecting robust growth for the global aspiration and biopsy needles market. According to the study, the market, valued at USD 777.29 million in 2023, is anticipated to witness a significant surge, reaching USD 1,405.2 million by 2033. This growth trajectory is underpinned by a strong Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period.
The escalating adoption of minimally invasive procedures across the healthcare industry is identified as a primary driver propelling market expansion. Aspiration and biopsy needles are integral components of these procedures, offering distinct advantages such as reduced patient discomfort, accelerated recovery periods, and improved patient outcomes. These factors underscore the increasing preference among healthcare providers and patients alike towards these advanced medical technologies.
To Get the Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14287
“The global aspiration and biopsy needles market is poised for substantial growth over the coming decade,” stated a Future Market Insights. “Technological advancements in medical devices, coupled with rising healthcare investments, are expected to further bolster market dynamics.”
The report also highlights geographical insights, indicating North America and Europe as key regions contributing significantly to market revenue. This trend is attributed to well-established healthcare infrastructures, high adoption rates of advanced medical technologies, and increasing prevalence of chronic diseases necessitating biopsy procedures.
As the market continues to evolve, stakeholders are urged to capitalize on emerging opportunities and technological innovations to sustain competitive advantage. Future Market Insights remains committed to providing actionable insights and strategic recommendations to support informed business decisions within the global healthcare landscape.
Top Highlights from the FMI’s Analysis of the Aspiration & Biopsy Needles Market:
- North America represented 34% market share in 2022. The regional market is projected to lead the market over the upcoming years. This can be attributed to the strong presence of market participants in the region. The introduction of new product lines and higher accessibility to treatment facilities in North America is pushing the market growth.
- Europe demonstrated a 26% overall market share. The industry growth has been catalyzed by many research and development activities and studies.
- Hospitals are expected to capture a significant portion of the market. In 2022, the segment acquired 46% of the market. Building upon the prior growth, the future market scope of the segment looks bright.
- The core biopsy needles segment attained a 58.60% market share in 2022. The demand graph of this product segment is projected to show an upward trend.
- India is expected to grow at lightning-bolt speed in the coming years. FMI has predicted an 8.3% CAGR for India from 2023 to 2033.
Request Customization of Report: https://www.futuremarketinsights.com/customization-available/rep-gb-14287
Keeping Abreast with the Market Ongoings: Market News
- Micro-Tech Endoscopy strives to develop high-quality products for endoscopic diagnosis. In October 2021, the company released an improved version of EUS needles, such as Trident FNB and Areus FNA.
- NeoDynamics AB is a MedTech company, which is devoted to enhancing breast cancer treatment and diagnosis. The company’s patent for a biopsy needle got approved in the United States, in August 2021, to be used in NeoNavia FlexiPulse probe.
- In January 2019, IZI Medical Products procured the needle product line of soft tissue biopsy and breast localization of Cook Medical.
Key Players in the Market:
- Merit Medical Systems
- Cook Group Incorporated
- Olympus Corporation
- Medtronic PLC
- Argon Medical Devices Inc.
- Boston Scientific Corporation
- Cardinal Health Inc.
- Conmed Corporation
- Inrad Inc.
Key Segments:
By Product Type:
- Biopsy Needles
- Aspiration Needles
By Application:
- Tumor/Cancer Applications
- Wound Applications
- Other Applications
By Procedure:
- Image-guided Procedures
- Non-image-guided Procedures
By End User:
- Hospitals & Surgical Centers
- Diagnostic Clinics & Pathology Laboratories
- Ambulatory Care Centers
- Research & Academic Institutes
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
A Comprehensive Full Report: https://www.futuremarketinsights.com/checkout/14287
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube